e-Article
Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in patients with operable HER2-positive early breast cancer
Document Type
Journal
Author
Piccart, Martine; Procter, Marion; Fumagalli, Debora; de Azambuja, Evandro; Clark, Emma; Ewer, Michael S.; Restuccia, Eleonora; Jerusalem, Guy; Dent, Susan; Reaby, Linda; Bonnefoi, Herve; Krop, Ian; Liu, Tsang-Wu; Pienkowski, Tadeusz; Toi, Masakazu; Wilcken, Nicolas; Andersson, Michael; Im, Young-Hyuck; Tseng, Ling-Ming; Lueck, Hans-Joachim; Colleoni, Marco; Monturus, Estefania; Sicoe, Mihaela; Guillaume, Sebastien; Bines, Jose; Gelber, Richard; Viale, Giuseppe; Thomssen, Christoph
Source
Subject
Language
English
ISSN
15387445